Infusion Pumps and Accessories Global Market

–Forecast to 2027

Infusion Pumps and Accessories global Market estimated to be worth

$14,886.0 million by 2027

IQ4I Research & Consultancy published a new report on “Infusion pumps and
accessories Global Market – Forecast To 2027” This report analyzes and studies the
overall market, major Drivers & Opportunities, Restraints & Threats in North America,
Europe, Asia-Pacific and Rest of the World.

IQ4I’s Report Contains 139 market data tables and 121 figures spread through 453
pages and an exhaustive TOC on “Infusion Pumps and Accessories Global Market
[Products {Infusion Pumps [External IP (Volumetric IP, Syringe IP, Ambulatory IP,
Disposable IP [Elastomeric IP, PCA IP], Enteral IP, Insulin IP), Implantable IP],
Consumables (Infusion Catheters, Infusion Sets, Cannula, Valves and Others),
Software and Services}; Application {Chemotherapy, Gastroenterology, Pain
management, Diabetes, Hematology, Total Parenteral Nutrition, Antibiotics,
IVIg/Specialty Pharmaceuticals and Others}; Mode of Administration (Intravenous,
Subcutaneous, Epidural, Intra-arterial, Enteral and Others); End-Users (Hospitals
[Emergency, Critical Care, Acute Care and General Ward], Ambulatory Surgical
Centers, Home Healthcare and Others); Region (North America, Europe, Asia-Pacific
and Rest of the World)]

Infusion pumps are the therapeutic medical devices used to administer chemotherapy drugs,
enteral and parenteral nutrients, insulin, blood and blood components, antibiotics,
immunoglobulin and specialty pharmaceuticals to the patients’ using a catheter or small
pumps by different modes of administrations like intravenous, subcutaneous, epidural, Intra-
arterial, intrathecal, intra-ventricular, and enteral. These pumps play a major role in
interruption-free medicine in all clinical settings and are an essential tool in preoperative,
critical, postoperative recovery, and pain management care.

According to IQ4I estimation, the infusion pumps and accessories global market is expected
to grow at mid single digit CAGR from 2020 to 2027, to reach $14,886.0 million by 2027.
Factors such as the increase in the aging population & subsequent rise in the incidence of
chronic diseases, technological innovations offering a wider scope of applications for
infusion pumps, and increase in the use of infusion products in home care settings are the
factors driving the market growth. The increasing trend for wireless infusion pumps,
increased use of smart pumps, and market expansion in emerging nations are expected to
offer potential opportunities.

However, various factors such as patient safety risks and medication errors associated with
infusion pumps, an increasing number of infusion pumps product recalls are limiting the
growth of infusion pumps and accessories global market. The threats for the infusion pumps

IQ4I Research & Consultancy Pvt. Ltd. Page 1

Infusion Pumps and Accessories Global Market

–Forecast to 2027

and accessories market include lack of cyber-security in wireless infusion pumps and
stringent regulatory requirements for the development and approval of new products.

The use of smart, multichannel, and disposable pumps in almost all the therapeutic areas
and insulin pumps for diabetes insulin management is the trend of this market, where, smart
pumps and wireless infusion pumps are used to avoid the wrong medication administration,
dosage errors, and are specially used for infusing very small dosage of medications.
Wearable drug delivery platforms such as the Sorrel device by Etian Group (Q-Core
Medical) which comes with a pre-filled preloaded platform that enhances user experience
and treatment adherence are being launched and the creation of De novo classification for
insulin pumps called Alternate Controller Enabled (ACE) pump or “ipumps” by USFDA that
will accelerated review, improve availability of intraoperable insulin pumps are some of the
upcoming trends in the field of infusion pumps.

The infusion pumps and accessories market is mainly segmented into products,
applications, mode of administration, end-users, and geography. The products market is
segmented into Infusion pumps, consumables, and Software and services, among them,
Infusion pumps accounted for the largest revenue in 2020 and are projected to grow at a mid
single digit CAGR from 2020 to 2027, owing to the huge demand for infusion pumps due to
increasing chronic illness incidences in the aging population, technological advancements,
and increased usage of smart infusion pumps with dosage error reduction software (DERS).
The application market is segmented into chemotherapy, gastroenterology, pain
management, diabetes, hematology, total parenteral nutrition, antibiotics, IVIg/Speciality
pharmaceutical, and others, among them, the diabetes segment commanded the largest
share and is expected to grow at a mid single digit CAGR from 2020 to 2027, due to the
rising incidence of diabetes in developed and emerging economies, increasing product
launches, development of smart insulin pumps and CGM integrated systems. The Mode of
administration market is segmented into intravenous, subcutaneous, epidural, intra-arterial,
enteral and others, among them, the intravenous segment commanded the largest share in
2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027, increasing
incidence of diabetes in all age group people decreased healthcare costs, improved therapy
compliance, increasing trend of self-medication are the factors driving the market growth.

Increasing incidence of diabetes globally, which affects an estimated 472.2 million people,
who require continuous monitoring and insulin administration is emerging as one of the
major opportunities for market players to invest more in R&D for designing innovative insulin

IQ4I Research & Consultancy Pvt. Ltd. Page 2

Infusion Pumps and Accessories Global Market

–Forecast to 2027

pumps. For instance, In September 2020, the FDA approved the latest automated artificial
pancreas system from Medtronic, the MiniMed 770G, for adults and children with Type I
diabetes as young as 2 years old.

Based on geography, the infusion pumps and accessories market is divided into North
America, Europe, Asia-Pacific, and the Rest of the world. The North American region
commanded the largest market revenue in 2020. High investments in healthcare
infrastructures and demand for quality services in this market are propelling the market
growth. However, the Asia-pacific region is expected to grow at a high single digit CAGR
from 2020 to 2027 due to increasing healthcare awareness, improved economic growth, and
increasing healthcare funding by the governments.

The overall infusion pumps market is consolidated with the top 8 companies commanding a
combined share of XX% of the market. To maintain a competitive edge these companies
have adopted different strategies, for instance, recently in 2021 Medtronic introduced the
first and only infusion set that can be worn up to 7 days. Similarly, Rusan pharmaceuticals
introduced infusion pumps (APOSAN) for the treatment of motor fluctuations (ON-OFF) in
patients with Parkinson’s Disease (PD) which is not sufficiently controlled by oral anti-
Parkinson’s medication currently available. APOSAN will be available in the form of
injections, pens, and continuous infusion pumps. Likewise in August 2020, Ivenix, Inc.
developed a smart infusion pump called Epic smart infusion pumps which helps in eliminate
infusion-based patient injury.

Among the Infusion pumps and accessories global market, Medtronic is recognized as the
global market leader with the largest share of XX% in the overall market and also considered
to be the leader in Insulin infusion pumps with a share of XX%. Similarly, Baxter International
Inc. is leading in the volumetric infusion pumps market with a share of XX%. Smiths Medical
commanded the major share of XX% and XX% in ambulatory infusion pumps and syringe
infusion pumps market respectively.

The increase in the number of clinical trials performed year-on-year is expected to drive the
infusion pumps market further, analysis by IQ4I research indicate that XX% of clinical trials
are in the phase-3 stage, XX% clinical trials in the phase-2/phase-3 stage, XX% clinical trials
are in the phase-2 stage, XX% clinical trials are in the phase-1/phase-2 stage, XX% clinical
trials are in phase-1 stage and XX% clinical trials are in early phase-1 stage. The majority of
clinical trials are focused on diabetes, pain, cancer, Parkinson’s diseases, and respiratory

IQ4I Research & Consultancy Pvt. Ltd. Page 3

Infusion Pumps and Accessories Global Market

–Forecast to 2027

depression, with PCA Pumps, Insulin pumps, and ambulatory pumps. However, the
increasing number of product recalls year-on-year is negatively influencing the market,
According to IQ4I analysis, product recalls by FDA from 2020 to 2021 include, XX% of class
I, XX% of Class II products.

Considering the huge unmet opportunity in this market many investors are funding the
various activities such as expansion of business, development of new infusion pump
technologies. According to IQ4I analysis, close to $XX million funding was provided starting
from January 2020. For instance, in April 2021, CeQur received $XX million in funding from
Credit Suisse Entrepreneur Capital Ltd and Endeavour vision to expand their commerical
operations.

Technological advancements such as next-generation barcode systems, infusion

teletherapy, mechatronic syringe pumps, and the availability of MRI-compatible infusion
pumps are positively influencing the infusion pumps market. For instance, in 2020, Codan
Argus introduced the next level of Barcode Assisted Infusion (BAI) volumetric infusion
pumps with a unique and innovative solution that increases both patient safety and workflow
efficiency. It is the safety package for critical treatments, such as the patient with cytostatics
for oncology.

As the COVID-19 started to spread through the world in early 2020, hospitals were
overwhelmed with the inflow of patients severely ill from the virus and faced a severe
shortage of vital infusion pumps and the increase in demand could not be met by
manufacturers as there was a total breakdown of supply chain due to restriction and
lockdowns to break the spread of the virus. Various stakeholders responded to this
extraordinary situation through innovative means such as manufacturers increasing number
of shifts, recruitment of stall and on-sight training, tie-up with multiple vendors. Similarly, the
regulatory agencies responded by relaxing the regulations and allowing modifications to
devices, and encouragement to develop a remotely operated device to limit the exposure of
healthcare workers. On the other hand, the hospitals responded by modifying the placement
of the device to reduce contact with ill patients, making changes in the duration of change of
IV sets to conserve consumables and use of gravity infusion rather than expensive devices.

Major players in the infusion pumps and accessories market include Medtronic PLC
(Ireland), Insulet Corporation (U.S.), Baxter International, Inc. (U.S.), ICU Medical Inc. (U.S.),
Terumo Corporation (Japan), B.Braun Melsungen AG (Germany), Becton Dickinson &

IQ4I Research & Consultancy Pvt. Ltd. Page 4

Infusion Pumps and Accessories Global Market

–Forecast to 2027

Company (U.S.), Tandem Diabetes Care Inc. (U.S.), Fresenius SE & Co. (Germany), and
Smiths Medical (U.S.).

Reasons for buying this report:

 Identification and analysis of the infusion pumps and accessories market
segments by application, products, mode of administration, end-users, and
geography.
 Analysis of the global market by identifying various sub-segments of the
infusion pumps and accessories market.
 Revenue forecast of the infusion pumps and accessories market and strategic
analysis of each submarket with respect to individual growth trends.
 Revenue forecast of the infusion pumps and accessories market with respect
to North America (U.S.), (Rest of N.A.), Europe (Germany, France, U.K. and
Rest of Europe), Asia-Pacific (Japan, China, India, Rest of APAC) and RoW
(Brazil, Rest of Latin America, Middle East & Others) regions.
 Market share analysis for overall infusion pumps global market, volumetric,
syringe, ambulatory, disposable, enteral, and insulin infusion pumps.
 Identification of the major market trends and factors driving or inhibiting the
growth of the infusion pumps and accessories global and its various sub-
markets.
 Analysis of the opportunities for stakeholders by identifying the high-growth
segments of the market.
 Analysis of the reimbursement, clinical trials, patent analysis, and product
recalls.
 The number of units sold analysis of Volumetric IP, Syringe IP, Ambulatory IP,
Disposable IP, Enteral IP, Insulin IP, and Implantable IP by region and country
wise.
 Installed base analysis of Volumetric IP, Syringe IP, Ambulatory IP, Enteral IP,
and Implantable IP by region and country wise.
 Profiles of major players in the Infusion pumps and accessories with details of
their product offerings, business strategies, SWOTs, market shares for
individual products reimbursement and, technological advancements.

IQ4I Research & Consultancy Pvt. Ltd. Page 5

Infusion Pumps and Accessories Global Market

–Forecast to 2027

FIGURE 1

INFUSION PUMPS AND ACCESSORIES GLOBAL MARKET SEGMENTATION

Infusion Pumps and Accessories Global Market

Mode of
Application Product Administration

Chemotherapy Software and Intravenous

Infusion pumps Consumables
Services

Gastroenterology External IP Implantable IP Subcutaneous

Pain Management Volumetric IP Epidural

Diabetes Syringe IP Intra arterial

Hematology Ambulatory IP Enteral

TPN Disposable IP Others

Antibiotics Enteral IP

IVIg Insulin IP

Others

IQ4I Research & Consultancy Pvt. Ltd. Page 6